Evidence map›Paper›PMID 39852822›Full record

ArticleVaccines2025

Safety and Immunogenicity of the Tetravalent Recombinant COVID-19 Protein Vaccine SCTV01E in Children and Adolescents Aged 3 to 17 Years: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial.

Fengcai Zhu, Ting Huang, Pengfei Jin, Linglin Zhang, Zhongqiang Jin, Wenli Zhang, Dongya Yuan, Zhong Wang, Yusong Deng, Jiaxin Li and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Fengcai ZhuJiangsu Provincial Center for Disease Control and Prevention, Jiangsu Provincial Academy of Preventive Medicine, Nanjing 210009, China.
Ting HuangSichuan Center for Disease Prevention and Control, Chengdu 610041, China.
Pengfei JinJiangsu Provincial Center for Disease Control and Prevention, Jiangsu Provincial Academy of Preventive Medicine, Nanjing 210009, China.
Linglin ZhangSichuan Center for Disease Prevention and Control, Chengdu 610041, China.
Zhongqiang JinSichuan Center for Disease Prevention and Control, Chengdu 610041, China.
Wenli ZhangSichuan Center for Disease Prevention and Control, Chengdu 610041, China.
Dongya YuanDazhu County Disease Prevention Control Center, Dazhu 635199, China.
Zhong WangDazhu County Disease Prevention Control Center, Dazhu 635199, China.
Yusong DengDazhu County Disease Prevention Control Center, Dazhu 635199, China.
Jiaxin LiDazhu County Disease Prevention Control Center, Dazhu 635199, China.
Xiao ShenDazhu County Disease Prevention Control Center, Dazhu 635199, China.
Yongpan FuBeijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing 100176, China.
Jian LiBeijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing 100176, China.
Xinjie YangBeijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing 100176, China.ORCID 0000-0002-4537-5303
Jing LiBeijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing 100176, China.
Liangzhi XieBeijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing 100176, China.ORCID 0000-0003-4504-7622

Funding

Beijing Science and Technology Planning Project Z231100004823003National Key Research and Development Program of China 2022YFC0870600National Key Research and Development Program of China 2023YFC3042100
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

children and adolescentsimmunogenicitymultivalent vaccinesafetySARS-CoV-2

Identifiers

PMID39852822
PMCPMC11768740

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.